Results for tag: "Cryptococcal Meningitis Drug"

Cryptococcal meningitis is a fungal infection of the brain and spinal cord caused by Cryptococcus neoformans. It is a serious and potentially life-threatening infection, particularly in immunocompromised individuals. Treatment of cryptococcal meningitis typically involves a combination of antifungal drugs, such as amphotericin B, flucytosine, and fluconazole. The cryptococcal meningitis drug market is a subset of the infectious diseases drug market. It is composed of a range of antifungal drugs used to treat cryptococcal meningitis. These drugs are typically administered intravenously or orally, depending on the severity of the infection. The market is expected to grow in the coming years due to the increasing prevalence of cryptococcal meningitis and the development of new antifungal drugs. Some of the major companies in the cryptococcal meningitis drug market include Pfizer, Merck, Novartis, GlaxoSmithKline, and AstraZeneca. Show Less Read more